RNCOS

Coagulation Factor Market Expected to Boost the Global Protein Therapeutics

Press Release   •   Oct 11, 2012 17:10 IST

According to our new report, “Global Protein Therapeutics Market Forecast to 2015”, the global protein therapeutic market witnessed promising growth in its coagulation factor segment. The sustained growth of the segment is most likely due to the rising cases of Hemophilia and other blood clotting-related disorders. While currently only one-fifth of the total hemophiliacs are treated by coagulation factors, this percentage is expected to rise in future, therefore acting as a major driver. Of the three coagulating recombinant coagulation factors - VII, VIII and IX, factor VIII had the largest market share in 2011 and the overall industry in recent times has also seen promising strategic activities and collaborative efforts in this respect.

According to our new report, “Global Protein Therapeutics Market Forecast to 2015”,there are many key protein therapeutic products under the phase-3 clinical trial development stage that may offer huge growth potential in future upon commercialization. The most promising pipeline is for the monoclonal antibody (mAb) products owing to the efficacy and specificity that they offer. It is estimated that the global protein therapeutics market will expand at a healthy CAGR of around 8% during 2012-2015 to reach US$ 143.4 Billion. Region-wise, the US continues to be the leader in protein therapeutics market, followed by the European countries. Japan, however, is emerging as one of the fastest growing markets for protein-based therapies as the country is grappling with high incidences of cancer and cardiovascular diseases.

The report provides an in-depth research and rational analysis of the current and expected status of the protein therapeutics market. It covers all the key aspects of the market and provides an in-depth insight into the key industry segments. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performance, and last but not the least, current and future market size. The report also investigates the current market trends and elucidates their impact on the current and future market performance. A brief description and key developments with respect to industry players have also been provided. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM389.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015 (http://www.rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (http://www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (http://www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (http://www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.